Algorae Pharmaceuticals Limited

ASX:1AI Stock Report

Market Cap: AU$11.8m

Algorae Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

David Hainsworth

Chief executive officer

AU$360.0k

Total compensation

CEO salary percentage16.7%
CEO tenure2.1yrs
CEO ownership1.2%
Management average tenure1.3yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

How Does Living Cell Technologies' (ASX:LCT) CEO Pay Compare With Company Performance?

Jan 07
How Does Living Cell Technologies' (ASX:LCT) CEO Pay Compare With Company Performance?

CEO Compensation Analysis

How has David Hainsworth's remuneration changed compared to Algorae Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$360kAU$60k

-AU$2m

Mar 31 2024n/an/a

-AU$2m

Dec 31 2023n/an/a

-AU$2m

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$40kAU$40k

-AU$2m

Compensation vs Market: David's total compensation ($USD234.07K) is about average for companies of similar size in the Australian market ($USD298.50K).

Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.


CEO

David Hainsworth (51 yo)

2.1yrs

Tenure

AU$360,000

Compensation

Mr. David Richard Hainsworth is an Associate Director with Alignment Capital, principally focused on the origination and execution of primarily Australian Stock Exchange based capital market transactions w...


Leadership Team

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairmanno dataAU$360.00k1.19%
A$ 140.0k
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELL1.3yrsAU$12.70k0.067%
A$ 7.9k
James Mckenna
Chief Scientific Officer1.4yrsno datano data
Jennifer Voon
Company Secretaryless than a yearno datano data

1.3yrs

Average Tenure

Experienced Management: 1AI's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
David Hainsworth
CEO & Executive Chairman2.1yrsAU$360.00k1.19%
A$ 140.0k
Carolyn Sue
Member of Medical Advisory Board & Chief Medical Officer of NTCELLno dataAU$12.70k0.067%
A$ 7.9k
Bradley Latham
Non-Executive Director1.3yrsAU$204.53k1.19%
A$ 140.0k
Bradley Dilkes
Non-executive Director2.1yrsAU$350.00k1.19%
A$ 140.0k

2.1yrs

Average Tenure

56yo

Average Age

Experienced Board: 1AI's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.